Current state of art after twenty years of the discovery of bioactive peptide lunasin
- 1 February 2019
- journal article
- review article
- Published by Elsevier in Food Research International
- Vol. 116, 71-78
Abstract
No abstract availableKeywords
Funding Information
- Instituto de Salud Carlos III (CD17/00014, AGL2015-66886-R)
- Ministerio de Economía y Competitividad (CD17/00014, AGL2015-66886-R)
This publication has 51 references indexed in Scilit:
- Antioxidant activity and protective effects of peptide lunasin against oxidative stress in intestinal Caco-2 cellsFood and Chemical Toxicology, 2014
- Use of phytochemomics to evaluate the bioavailability and bioactivity of antioxidant peptides of soybean β‐conglycininElectrophoresis, 2013
- Soypeptide lunasin in cytokine immunotherapy for lymphomaCancer Immunology, Immunotherapy, 2013
- Endocytic Mechanism of Internalization of Dietary Peptide Lunasin into Macrophages in Inflammatory Condition Associated with Cardiovascular DiseasePLOS ONE, 2013
- Sequential release of milk protein–derived bioactive peptides in the jejunum in healthy humansThe American Journal of Clinical Nutrition, 2013
- The soybean peptide lunasin promotes apoptosis of mammary epithelial cells via induction of tumor suppressor PTEN: similarities and distinct actions from soy isoflavone genisteinGenes & Nutrition, 2012
- Recombinant production of the therapeutic peptide lunasinMicrobial Cell Factories, 2012
- Complementary Roles in Cancer Prevention: Protease Inhibitor Makes the Cancer Preventive Peptide Lunasin BioavailablePLOS ONE, 2010
- Recombinant expression systems in the pharmaceutical industryApplied Microbiology and Biotechnology, 2004
- Patent information for strategic technology managementWorld Patent Information, 2003